EB-0176
EB-0176 is a potent inhibitor of ER α-glucosidases (α-Glu) Iand II with IC50s of 0.6439 and 0.0011 μM, respectively. EB-0176 is a N-substituted derivative of valiolamine with broad-spectrum antiviral. EB-0176 has the potential for the reseach of broad-spectrum agent against the existing and emerging viruses[1].
Product Specifications
CAS Number
2758314-64-4
UNSPSC
12352005
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/eb-0176.html
Solubility
10 mM in DMSO
Smiles
O[C@@H]1[C@H]([C@@H]([C@](O)(C[C@@H]1NCCCCCCNC2=C(C=C(C=C2)C3=NC=CC=N3)[N+]([O-])=O)CO)O)O
Molecular Formula
C23H33N5O7
Molecular Weight
491.54
References & Citations
[1]Karade SS, et al. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity. J Med Chem. 2021;64 (24) :18010-18024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![NR2E3 Mouse Monoclonal Antibody [Clone ID: OTI3G3]](https://cdn.genprice.uk/products/937/68dd18b9061270361e907e8a/imageurl/cf806218.webp)
![cis-4-[[2-(1H-Benzimidazol-6-ylamino)-8-quinazolinyl]oxy]-cyclohexanol](https://cdn.genprice.uk/products/572/636434222644/imageurl/trc-b197005-5mg.webp)
TRC-B197005-5MG 5 mg
cis-4-[[2-(1H-Benzimidazol-6-ylamino)-8-quinazolinyl]oxy]-cyclohexanol
Sign In for Pricing
View Details